Also listed under Arthritis, Autoimmune Diseases
ClinicalTrials.gov term: Arthritis, Rheumatoid
Rheumatoid Arthritis clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
31 trials changed in the last 30 days: 0 stopped, 16 with notable changes, 15 with minor changes only.
- Notable: MYTP01 for Immune-Mediated Diseases Start date pushed from Oct 2026 to Dec 2026
- Minor: Neuropathic Hand Pain in Rheumatoid Arthritis Study completion pushed from Jun 15, 2026 to Sep 15, 2027
- Notable: Pain Phenotyping of Rheumatic Diseases - An Observational Study Recruitment opened
- Minor: Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis Trial completed
- Notable: AURORA · AZD0120 in Autoimmune Diseases Phase changed: Phase 1 → Phase 1/2
- Notable: LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis Primary completion pushed from Dec 15, 2025 to Nov 15, 2026
- Minor: NKX019 · Immune-Mediated Diseases (Ntrust-2) Trial sites reduced: 18 → 12 locations
- Notable: CO2I2 · COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Primary completion pushed from Mar 31, 2027 to Jan 31, 2028
- Minor: Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis Trial completed
- Notable: NUTRA · Nutrition in Rheumatoid Arthritis Primary endpoint(s) modified
- Notable: Monarch · Tornier Perform™ Reversed Monopost Study Recruitment opened
- Minor: Different Doses of ELV001 · Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY) Trial sites expanded: 30 → 34 locations
- Minor: JADE201 · Rheumatoid Arthritis Trial sites expanded: 3 → 8 locations
- Minor: BMS-986528 · Refractory Rheumatoid Arthritis Start date changed from estimate of Sep 15, 2026 to Oct 6, 2026
- Notable: Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care · Rheumatoid Arthritis Primary completion pushed from Sep 2027 to May 2028
- Notable: YTS109 Cell in R/R Autoimmune Diseases Primary completion pushed from May 19, 2026 to May 19, 2027
- Notable: Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion and Intra-Articular Injection for RA Primary and study completion pushed from Sep 2026 to Sep 2028
- Minor: Cityview · PET-Based Imaging of Radiolabeled CIT-013 Trial completed
- Minor: Citydream · CIT-013 in RA Patients Trial completed
- Notable: BEN301 Injection · Autoimmune Diseases Enrollment reduced: 24 → 2 participants
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-04 | NCT07916623 Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis | Ege University new | |
| 2026-10-23 | NCT07892651 MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | Axiom Bioregistry new | |
| 2026-10-08 | NCT07866326 Prevalence of Adrenal Insufficiency and Associated Factors in Rheumatoid Arthritis… | Bursa Yuksek Ihtisas Training and Research Hospital new | |
| 2026-09-30 | NCT07849673 Improving ILD Screening in Patients With RA and SSc Using EHR-Embedded CDS and PRO Tools | Foundation for Advancing Science Technology Education and Research new | |
| 2026-09-28 | NCT07844564 Effects of Nonsurgical Periodontal Treatment on GCF Calprotectin and IL-10 in Rheumatoid… | Ondokuz Mayıs University new | |
| 2026-09-17 | NCT07825233 Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform | Centre Hospitalier Universitaire Vaudois new | |
| 2026-09-02 | NCT07800871 FT839 in Autoimmune Diseases | Fate Therapeutics new | Phase 1/2 |
| 2026-08-21 | NCT07779616 Study of PTC844 in Participants With Active Rheumatoid Arthritis | PTC Therapeutics new | Phase 2 |
| 2026-08-19 | NCT07774507 Twenty-four Hour Movement Behaviors and Atherosclerotic Risk | São Paulo State University new | |
| 2026-08-18 | NCT07769619 Integrative AI-Based Multiomic and Neurophysiological Profiling of Chronic Pain in… | 4th Military Clinical Hospital with Polyclinic, Poland new |
Active trials by phase
| Early Phase 1 | 8 | |
| Phase 1 | 50 | |
| Phase 1/2 | 15 | |
| Phase 2 | 46 | |
| Phase 2/3 | 4 | |
| Phase 3 | 20 | |
| Phase 4 | 33 |
Not charted: 334 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
Zimmer Biomet (25) · Assiut University (18) · MicroPort Orthopedics Inc. (10) · Sohag University (10) · Medacta International SA (9) · Tanta University (9) · Aesculap AG (7) · Diakonhjemmet Hospital (7) · Assistance Publique - Hôpitaux de Paris (6) · Bristol-Myers Squibb (6)
Get alerts when Rheumatoid Arthritis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.